Ken-Jec 40 Side Effects
Generic name: triamcinolone
Note: This document contains side effect information about triamcinolone. Some of the dosage forms listed on this page may not apply to the brand name Ken-Jec 40.
Some side effects of Ken-Jec 40 may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to triamcinolone: injection suspension
Along with its needed effects, triamcinolone (the active ingredient contained in Ken-Jec 40) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking triamcinolone:More common
- blurred vision
- decrease in the amount of urine
- fast, slow, pounding, or irregular heartbeat or pulse
- mental depression
- mood changes
- noisy, rattling breathing
- numbness or tingling in the arms or legs
- pounding in the ears
- shortness of breath
- swelling of the fingers, hands, feet, or lower legs
- trouble thinking, speaking, or walking
- troubled breathing at rest
- weight gain
- Abdominal cramping and/or burning (severe)
- abdominal pain
- bloody, black, or tarry stools
- cough or hoarseness
- darkening of skin
- decreased vision
- dry mouth
- eye pain
- eye tearing
- facial hair growth in females
- fever or chills
- flushed, dry skin
- fruit-like breath odor
- full or round face, neck, or trunk
- heartburn and/or indigestion (severe and continuous)
- increased hunger
- increased thirst
- increased urination
- loss of appetite
- loss of sexual desire or ability
- lower back or side pain
- menstrual irregularities
- muscle pain or tenderness
- muscle wasting or weakness
- pain in back, ribs, arms, or legs
- painful or difficult urination
- skin rash
- trouble healing
- trouble sleeping
- unexplained weight loss
- unusual tiredness or weakness
- vision changes
- vomiting of material that looks like coffee grounds
Some side effects of triamcinolone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:Incidence not known
- Blemishes on the skin
- dry, scaly skin
- feeling of constant movement of self or surroundings
- full or bloated feeling
- increased appetite
- increased hair growth on the face, forehead, back, arms, and legs
- large, flat, blue, or purplish patches in the skin
- pitting or depression of the skin at the injection site
- reddish purple lines on the arms, face, legs, trunk, or groin
- redness of the skin
- redness, swelling, tenderness, or pain at the injection site
- sensation of spinning
- small, red, or purple spots on the skin
- thin, fragile, or shiny skin
- thinning of the scalp hair
For Healthcare Professionals
Applies to triamcinolone: compounding powder, inhalation aerosol, inhalation aerosol with adapter, injectable suspension, oral tablet
Cardiovascular side effects have included fluid retention, sodium retention, congestive heart failure, potassium loss, hypokalemic alkalosis, and hypertension.
Musculoskeletal side effects have included aseptic necrosis of femoral and humeral heads, calcinosis (following intra-articular or intra-lesional use), Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, postinjection flare (following intra-articular use), steroid myopathy, tendon rupture, and vertebral compression fractures. Postmarketing experience has included very rare reports of bone mineral density loss and osteoporosis, especially with prolonged use, which may lead to an increased risk of fractures.
Decreases in bone density of the total hip and the trochanter have been reported with the use of inhaled triamcinolone acetonide in a study (n=109) of premenopausal women with asthma. The yearly change in bone density at the total hip and the trochanter showed a greater decline as the number of puffs per day of the inhaled glucocorticoid increased.
Gastrointestinal side effects have included peptic ulcer with potential perforation and hemorrhage, perforation of small and large bowel, pancreatitis, abdominal distention, and ulcerative esophagitis.
Dermatologic side effects have included impaired wound healing, thin, fragile skin, petechiae and ecchymoses, facial erythema, increased sweating, and suppressed reactions to skin tests.
Nervous system side effects have included convulsions, increased intracranial pressure with papilledema, vertigo, and headache.
Endocrine side effects have included development of cushingoid state, menstrual irregularities, suppression of growth in children, manifestations of latent diabetes, increased requirements for insulin or oral hypoglycemic agents in diabetics, decreased carbohydrate tolerance, and secondary adrenocortical and pituitary unresponsiveness.
Ocular side effects have included posterior subcapsular cataracts, increased intraocular pressure, glaucoma, and exophthalmos. Retinal and choroidal occlusion as a complication after posterior sub-Tenon triamcinolone (the active ingredient contained in Ken-Jec 40) injection has been reported.
Metabolic side effects have included negative nitrogen balance due to protein catabolism.
Hypersensitivity side effects have included anaphylactoid reactions, anaphylaxis, and angioedema.
Other side effects have included abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, moon face, malaise, and weight gain.
Local side effects have included injection site infections following non-sterile administration.
More Ken-Jec 40 resources
- Triamcinolone Monograph (AHFS DI)
- Triamcinolone Prescribing Information (FDA)
- Triamcinolone Professional Patient Advice (Wolters Kluwer)
- Aristocort Advanced Consumer (Micromedex) - Includes Dosage Information
- Aristocort Prescribing Information (FDA)
- Aristocort MedFacts Consumer Leaflet (Wolters Kluwer)
- Azmacort Prescribing Information (FDA)
- Azmacort Consumer Overview
- Azmacort aerosol MedFacts Consumer Leaflet (Wolters Kluwer)
- Kenalog-10 Prescribing Information (FDA)
- Kenalog-10 suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Kenalog-40 Prescribing Information (FDA)
- Kenalog-40 suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Triamcot Advanced Consumer (Micromedex) - Includes Dosage Information
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.